Archive for September 2022

Dandorph stepped into the role in January of 2020. After two-and-a-half years spent fighting Covid, he’s now ready to take on new challenges. Read More

Unsurprisingly, Massachusetts scored highly in education, access to capital and tech and innovation. But the Bay State was nearing the bottom of the barrel for the cost of doing business and the cost of living. Read More

One Beverly construction firm is working to transition to its second generation. Here’s our annual list of the state’s largest family-owned businesses. Read More

Biogen has spent much of the year shedding assets following the disastrous rollout of its first Alzheimer’s disease drug. Will its new Alzheimer’s drug stop that decline? Read More

Good morning, Boston. Here are the five things you need to know to start your busy Thursday. Read More

Christopher Ianelli, founder and CEO of iSpecimen, is leaving the company following a "mutual agreement" between him and the board of directors. Read More

The measure ups the ante in the city’s drive to cut emissions from its buildings, Boston’s largest source of emissions. Existing buildings are already required to reach net zero by the year 2050. Read More

Positive data on the Cambridge company’s Alzheimer’s drug released late Tuesday restored some investor and analyst confidence. But patient advocates are holding out for full study results. Read More

SmartBear Software is making moves to accommodate what one executive called strong top line growth for the Somerville company, which employs 300 workers in the Bay State. Read More